The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of ...

How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

From 2013-2014 to August 2021-August 2023, there were small increases in the percentage of children and adolescents with obesity, as well as in adults with severe obesity (but not obesity). There were ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

While it seems like we’re getting slimmer as a population, a new report suggests that’s not necessarily the case: It found ...

JAX researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Doctors say women tend to ignore a lot of signs and symptoms indicating serious health risks. Here is a comprehensive guide ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...